Bradley Jeffrey D, Hope Andrew, El Naqa Issam, Apte Aditya, Lindsay Patricia E, Bosch Walter, Matthews John, Sause William, Graham Mary V, Deasy Joseph O
Department of Radiation Oncology, Washington University School of Medicine, St Louis, MO 63110, USA.
Int J Radiat Oncol Biol Phys. 2007 Nov 15;69(4):985-92. doi: 10.1016/j.ijrobp.2007.04.077. Epub 2007 Aug 6.
To test the Washington University (WU) patient dataset, analysis of which suggested that superior-to-inferior tumor position, maximum dose, and D35 (minimum dose to the hottest 35% of the lung volume) were valuable to predict radiation pneumonitis (RP), against the patient database from Radiation Therapy Oncology Group (RTOG) trial 9311.
The entire dataset consisted of 324 patients receiving definitive conformal radiotherapy for non-small-cell lung cancer (WU = 219, RTOG 9311 = 129). Clinical, dosimetric, and tumor location parameters were modeled to predict RP in the individual datasets and in a combined dataset. Association quality with RP was assessed using Spearman's rank correlation (r) for univariate analysis and multivariate analysis; comparison between subgroups was tested using the Wilcoxon rank sum test.
The WU model to predict RP performed poorly for the RTOG 9311 data. The most predictive model in the RTOG 9311 dataset was a single-parameter model, D15 (r = 0.28). Combining the datasets, the best derived model was a two-parameter model consisting of mean lung dose and superior-to-inferior gross tumor volume position (r = 0.303). An equation and nomogram to predict the probability of RP was derived using the combined patient population.
Statistical models derived from a large pool of candidate models resulted in well-tuned models for each subset (WU or RTOG 9311), which did not perform well when applied to the other dataset. However, when the data were combined, a model was generated that performed well on each data subset. The final model incorporates two effects: greater risk due to inferior lung irradiation, and greater risk for increasing normal lung mean dose. This formula and nomogram may aid clinicians during radiation treatment planning for lung cancer.
利用华盛顿大学(WU)患者数据集对放射治疗肿瘤学组(RTOG)9311试验的患者数据库进行测试,WU患者数据集分析表明肿瘤上下位置、最大剂量和D35(肺体积最热的35%的最小剂量)对预测放射性肺炎(RP)具有重要价值。
整个数据集由324例接受非小细胞肺癌根治性适形放疗的患者组成(WU = 219例,RTOG 9311 = 129例)。对临床、剂量学和肿瘤位置参数进行建模,以预测各个数据集和合并数据集中的RP。使用Spearman等级相关性(r)评估与RP的关联质量,用于单变量分析和多变量分析;使用Wilcoxon秩和检验测试亚组之间的比较。
WU预测RP的模型在RTOG 9311数据中表现不佳。RTOG 9311数据集中最具预测性的模型是单参数模型D15(r = 0.28)。合并数据集后,最佳衍生模型是由平均肺剂量和肿瘤上下总体积位置组成的双参数模型(r = 0.303)。使用合并的患者群体推导出预测RP概率的方程和列线图。
从大量候选模型中得出的统计模型为每个子集(WU或RTOG 9311)生成了经过良好调整的模型,但应用于另一个数据集时表现不佳。然而,当数据合并时,生成的模型在每个数据子集上都表现良好。最终模型包含两种效应:下肺照射导致的风险增加,以及正常肺平均剂量增加导致的风险增加。该公式和列线图可能有助于临床医生在肺癌放射治疗计划期间做出决策。